people

• Overview
• Grant Central
• Medvane
• Profiles

learning

• Overview
• Colloquium Series
• Conferences and Seminars
• Dean's Symposium
• Leder Human Biology
• Biomedical Informatics Training
• Biostatistics Training
• Clinical Investigator Training Program
• Scholars in Clinical Science
• KL2 Medical Research Investigator Training
• Introduction to Clinical Investigation
• Biostatistics Seminar Series
• Genetics Courses
• Imaging Courses

resources

• Overview
• Pilot Funding
• AEGIS Influenza
• Atlas
• Community-Based Participatory Research
• Community Connect to Research
• Consulting Programs
• Core Facilities
• HarvardTrials
• Health Disparities Research Program
• In/Outpatient Resources
• Laboratory for Innovative Translational Technologies
• Law and Health Policy
• Medications and Society
• Pathology Specimen Locator
• SHRINE
• Webdash

Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT)

The Laboratory for Innovative Translational Technologies (LITT), originally created and located at the Harvard School of Dental Medicine to provide the Harvard research community (basic and clinical researchers) with early access to enabling leading-edge genomic and proteomic technologies, is now an integral part of the Harvard Catalyst. Predating the Harvard Catalyst by a year, but prescient in its mission, the LITT was designed to accelerate the translation of laboratory research in therapeutics and diagnostics into the clinic.

Now referred to as the Harvard Catalyst - Laboratory for Innovative Translational Technologies (HC-LITT), HC-LITT's model is a 'collaborative research model' that is very distinct from the 'traditional core' centers. The model is to bring together a myriad of innovative technologies in one place and put them to use in the hands of investigators from diverse disciplines with a common goal of addressing questions with human translational impact. HC-LITT attempts to provide a great networking environment between the Harvard research community and companies, a "win-win" environment.

The HC-LITT will seek proposals for innovative and unique projects requiring state of the art technology through its website; frequent seminars, demonstrations, and workshops; and a network of like minded first-user, experts, or technology enthusiasts from the community of students, fellows and faculty of Harvard's Medical, Arts and Sciences, and Engineering Schools as well as the eight teaching hospitals. Keeping a sharp focus on translational efforts, the HC-LITT will have an advisory board composed of CEOs, CFOs, CSOs, CTOs, life science investors and scientific experts who understand how discovery moves from lab to the market. These advisors will serve as the eyes and ears of the HC-LITT community for the latest technologies around the world. Translation will be enhanced by the interaction of all of these groups as well as an active effort by the HC-LITT to identify opportunities for academic/industry and industry/industry collaborations making the way for SBIR/STTR grants and even formation of new companies. The HC-LITT is a marketplace of new ideas, innovative approaches, cutting-edge technologies and entrepreneurship.

Contact:

HC-LITT Director, Winston Patrick Kuo, D.D.S., D.M.Sc.
E-mail

HC-LITT Associate Director, Robert J. Distel, Ph.D.
E-mail

HC-LITT Medical Director, Eva C. Guinan, M.D.
E-mail

HC-LITT Novel Clinical and Translational Methodologies Director,
Vikas P. Sukhatme, M.D., Ph.D.
E-mail